There it is, the giant lurking..... well-positioned to explore the next stage of development of OrthoATI, targeting US FDA registration and working with US-based corporate adviser to identify potential strategic partners to progress OrthoATI without the need for significant investment in the near term. Steady as she goes as far a spending on product manufacturing, operating overheads and business development. Gearing up for near term US and ROW sales. Exciting times ahead.
OCC Price at posting:
$1.48 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)